Why did ALMDT.PA stock fall so sharply today?

ALMDT.PA stock dropped **-18.97%** amid heavy volume and no single public catalyst; the move reflects sentiment, technical stops and liquidity concerns rather than a confirmed company announcement.

What is Meyka AI’s view on ALMDT.PA stock performance?

Meyka AI rates ALMDT.PA **68.89/100 (B, HOLD)** and models a **yearly price of €2.91**, indicating downside risk; this grade factors benchmarks, sector data, growth and analyst inputs.

What key levels should traders watch for ALMDT.PA stock?

Traders should watch intraday support at **€4.97**, resistance at **€5.60**, and broader technical zones near the 50-day **€4.27** and 200-day **€2.97** averages for validation.

How does ALMDT.PA stock compare to Healthcare peers?

Compared with Healthcare/Medical-Devices peers, ALMDT.PA shows higher valuation compression and weaker liquidity metrics; peers typically trade at higher P/E and current ratios, which raises relative risk.

EU Stocks

ALMDT.PA (Median Technologies SA) down 18.97% to €5.34 intraday 16 Feb 2026: implications for EURONEXT traders

ByDanny Kontos February 16, 2026

The ALMDT.PA stock is trading sharply lower intraday after a -18.97% move to €5.34 on 16 Feb 2026, making it one of EURONEXT’s top losers. Volume is elevated at 1,075,181 shares versus an average of 459,151, highlighting active selling. The drop follows a gap from yesterday’s €6.59 close and leaves the share price well above the 52-week low but below the 50-day average, forcing traders to reassess risk on this Healthcare medical-device software name.